Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
Here is how Alnylam Pharmaceuticals (ALNY) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.…
38,800€
-6,73%
Echtzeit-Aktienkurs Collegium Pharmaceutical Inc.
Bid:
Ask:
Nachrichten zur Collegium Pharmaceutical Inc. Aktie
Collegium Pharmaceutical erhöht die Prognose - Aktie zieht auf Allzeithoch!
Collegium Pharmaceutical konzentriert sich auf die Entwicklung und Vermarktung von Medikamenten für die Schmerzbehandlung. Das Produktportfolio besteht aus mehreren Produkten…
Dont Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI
Two medical sector stocks are standing out among the recent additions to the Zacks Rank #1 (Strong Buy) list in…
Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?
The consensus price target hints at a 33.9% upside potential for Collegium Pharmaceutical (COLL). While empirical research shows that this…
Collegium Pharmaceutical, Inc. 2025 Q1 - Results - Earnings Call Presentation
…
Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript
…
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?
Collegium Pharmaceutical (COLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended December 2024,…
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 14.94% and 0.86%, respectively, for the quarter ended December 2024. Do…
Collegium Pharmaceutical beats Q4 estimates, shares rise 6.3% By Investing.com
Collegium Pharmaceutical beats Q4 estimates, shares rise 6.3%…
Collegium Pharmaceutical stock hits 52-week low at $28.75 By Investing.com
Collegium Pharmaceutical stock hits 52-week low at $28.75…
Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion
…
Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript
…
Collegium Pharmaceutical: Making Steady Progress
…
Collegium Pharmaceutical: Diversifying And Growing
…
Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript
…
Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
Collegium Pharmaceutical (COLL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
Collegium Pharmaceutical: Some Positives From Its Quarterly Miss
…
Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript
…
Collegium Pharmaceutical to redeem outstanding 2.625% convertible senior notes due 2026
…
Collegium Pharmaceutical Q4: The Beat Goes On
…